Cozad Asset Management Inc. lessened its stake in shares of CVS Health Corp (NYSE:CVS) by 50.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,628 shares of the pharmacy operator’s stock after selling 39,016 shares during the quarter. Cozad Asset Management Inc.’s holdings in CVS Health were worth $2,105,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of CVS. Geode Capital Management LLC increased its position in CVS Health by 36.2% during the 4th quarter. Geode Capital Management LLC now owns 16,462,292 shares of the pharmacy operator’s stock worth $1,076,697,000 after purchasing an additional 4,376,604 shares in the last quarter. Ellis Investment Partners LLC increased its position in CVS Health by 5,752.4% during the 1st quarter. Ellis Investment Partners LLC now owns 1,858,328 shares of the pharmacy operator’s stock worth $1,858,000 after purchasing an additional 1,826,575 shares in the last quarter. Parametric Portfolio Associates LLC increased its position in CVS Health by 19.7% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 5,150,680 shares of the pharmacy operator’s stock worth $280,661,000 after purchasing an additional 847,460 shares in the last quarter. RNC Capital Management LLC purchased a new stake in CVS Health during the 1st quarter worth about $42,243,000. Finally, Poplar Forest Capital LLC purchased a new stake in CVS Health during the 2nd quarter worth about $35,405,000. Hedge funds and other institutional investors own 76.06% of the company’s stock.
CVS has been the subject of a number of recent research reports. Morgan Stanley reiterated a “buy” rating and set a $74.00 price objective on shares of CVS Health in a research report on Sunday, August 11th. Mizuho set a $71.00 price target on CVS Health and gave the company a “buy” rating in a report on Wednesday, June 5th. Bank of America lifted their price target on CVS Health from $72.00 to $75.00 and gave the company a “buy” rating in a report on Thursday. Deutsche Bank started coverage on CVS Health in a report on Thursday. They issued a “buy” rating and a $91.00 price target for the company. Finally, Cowen restated an “outperform” rating and issued a $76.00 price target (up previously from $69.00) on shares of CVS Health in a report on Tuesday, August 27th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $75.91.
Shares of NYSE CVS traded up $0.31 during midday trading on Thursday, hitting $64.30. The stock had a trading volume of 80,343 shares, compared to its average volume of 10,862,482. The company has a market capitalization of $82.82 billion, a price-to-earnings ratio of 9.06, a PEG ratio of 1.39 and a beta of 0.85. CVS Health Corp has a 1-year low of $51.72 and a 1-year high of $82.15. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The company has a fifty day moving average price of $59.26 and a 200 day moving average price of $55.85.
CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.19. The business had revenue of $63.43 billion for the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The company’s revenue was up 35.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.69 EPS. On average, research analysts forecast that CVS Health Corp will post 6.96 EPS for the current year.
CVS Health Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Featured Story: What is the definition of a trade war?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.